Actions, AD/CVD cases, ITC investigations, hearings, OFAC actions, and HTS codes.
Type at least 2 characters to search the public source record.
The Chinese car ban bill would tie some vehicle approvals to five years of U.S. manufacturing before enactment.
Xi's September 24 investment appeal leaves a site-selection problem: the same Chinese-backed factory can face different CFIUS exposure on different parcels.
A Chinese ship-fee restart on the existing schedule would widen the cost gap between vessels with Chinese owners or operators and other Chinese-built ships.
For specified China chipmaking exports, an unknown production node can trigger a license requirement even when the customer is absent from the Entity List.
Old Chinese vehicle code needs a dated supply and maintenance record before a U.S. automaker can rely on the BIS legacy-software exclusion.
A Chinese tariff cut could reduce U.S. medical-device prices while a 20% domestic-product preference still shapes government tender comparisons.
A longer U.S.-China truce could steady existing rare-earth supplies while a factory move can still require new permission and a pause under the affected permit.
A tariff concession for India or China would not, by itself, resolve restrictions on a supplier's bank under the Russia sanctions bill.
China's openness to WTO subsidy talks leaves unresolved the EU's plan for broader state-enterprise rules.
China's EV price crackdown can coexist with stronger overseas competition as Beijing promotes export insurance and cheaper delivery and parts support.